Sertraline for Bulimia Nervosa

What research says

EveryOption research summary

An open-access evidence review reports one 12-week placebo-controlled study in outpatients with bulimia nervosa that found fewer binge-eating crises and purging episodes with sertraline; one older study is promising but limited evidence. This assessment does not compare every option or determine personal suitability.

See sourcePubMed Central open-access full text · checked Oct 16, 2026

Source for the opening statement

Relationship: supports bounded conclusion

This statement’s scope

Population: outpatients with bulimia nervosa as described by the evidence review

A supporting passage is not published here. Inspect the statement scope and linked source.

Published pointer: /document/passage

All published source details

Population: outpatients with bulimia nervosa as described by the evidence review
Completeness: Not assessed
Need: bulimia nervosa

Source collection coverage: global
Source pointer: /document/passage

Open published source

EveryOption’s published assessment

Promising, with important evidence limits

Published Sep 21, 2026 · revision 1

Find care

Choose a place to see published offerings. A listing does not confirm current availability.

Choose a place Compare published Treatments for this Need

Why this Treatment appears for this Need

Why this Treatment appears in the Need landscape, separate from the research conclusion.

See relationship sourcePubMed Central open-access full text · checked Oct 16, 2026

Relationship: small trial of sertraline for bulimia nervosa